Classification of the myelodysplastic syndrome in a national registry of recently diagnosed patients.
It is not known to what extent the WHO classification scheme for MDS has been adopted in clinical practice. We reviewed the medical records of 200 newly diagnosed MDS patients enrolled in our national registry during the years 2006-2008 to determine the scheme used. Clear WHO subtypes were recorded for 45.0% of patients, compared to 5.5% for FAB subtypes; 28.0% had MDS documented but without WHO or FAB subtype, and for 22.5%, the schema was unclear. Although many MDS patients do not have a subtype or schema documented, when they do, the WHO system is widely used.